{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:43Z","timestamp":1792788523384,"version":"4.5.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008307","name":"Promedica Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008307","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stiftung Experimentelle Biomedizin"},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210436","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T13:46:07Z","timestamp":1548423967000},"page":"e0210436","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study"],"prefix":"10.1371","volume":"14","author":[{"given":"Nina","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Biedermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Butter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan R.","family":"Vavricka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Navarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Rogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6729-1469","authenticated-orcid":true,"given":"Michael","family":"Scharl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Swiss IBD Cohort Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"issue":"46","key":"ref1","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","article-title":"Extraintestinal manifestations in inflammatory bowel disease","volume":"11","author":"S Danese","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"CN Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00054725-200405000-00005","article-title":"Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study","volume":"10","author":"E Ricart","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"ref4","first-page":"297","article-title":"Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis","volume":"125","author":"JL Mendoza","year":"2005","journal-title":"Medicina clinica"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0016-5085(79)90391-3","article-title":"National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications","volume":"77","author":"GB Rankin","year":"1979","journal-title":"Gastroenterology"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0889-8553(01)00019-X","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"31","author":"CG Su","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients","volume":"55","author":"AJ Greenstein","year":"1976","journal-title":"Medicine"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0016-5085(75)80270-8","article-title":"Clinical patterns in Crohn's disease: a statistical study of 615 cases","volume":"68","author":"RG Farmer","year":"1975","journal-title":"Gastroenterology"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients","volume":"23","author":"FT Veloso","year":"1996","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 4","key":"ref10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2036.2004.02055.x","article-title":"Review article: skin complications associated with inflammatory bowel disease","volume":"20","author":"F. Tavarela Veloso","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"SR Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1026629528233","article-title":"Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis","volume":"44","author":"KM Das","year":"1999","journal-title":"Dig Dis Sci"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal Manifestations of Inflammatory Bowel Disease","volume":"21","author":"SR Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","article-title":"Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort","volume":"21","author":"SR Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"ref15","first-page":"711","article-title":"Extracolonic diagnoses in ulcerative colitis: an epidemiological study","volume":"85","author":"U Mons\u00e9n","year":"1990","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"ref16","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"40","author":"S Ardizzone","year":"2008","journal-title":"Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00004836-200607000-00003","article-title":"Extraintestinal manifestations of inflammatory bowel diseases","volume":"40","author":"SR Kethu","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0016-5085(94)90066-3","article-title":"A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody","volume":"107","author":"S Bhagat","year":"1994","journal-title":"Gastroenterology"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/gast.1997.v112.pm9178675","article-title":"Genetic markers may predict disease behavior in patients with ulcerative colitis","volume":"112","author":"M Roussomoustakaki","year":"1997","journal-title":"Gastroenterology"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","article-title":"Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease","volume":"118","author":"TR Orchard","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/gast.2002.35396","article-title":"Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes","volume":"123","author":"TR Orchard","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.crohns.2012.02.020","article-title":"TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease","volume":"7","author":"C Ciccacci","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MD.0b013e318187cc9c","article-title":"Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients","volume":"87","author":"D Farhi","year":"2008","journal-title":"Medicine"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ibd.20807","article-title":"Mucocutaneous manifestations in inflammatory bowel disease","volume":"15","author":"I Y\u00fcksel","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ije\/dyn180","article-title":"Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)","volume":"38","author":"V Pittet","year":"2009","journal-title":"Int J Epidemiol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jgh.12352","article-title":"Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease","volume":"29","author":"J Ampuero","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.crohns.2012.01.002","article-title":"Maternal imprinting and female predominance in familial Crohn's disease","volume":"6","author":"Z Zelinkova","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"e113684","DOI":"10.1371\/journal.pone.0113684","article-title":"Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases","volume":"9","author":"D Chang","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12016-017-8617-4","article-title":"Skin Manifestations of Inflammatory Bowel Disease","volume":"53","author":"T Greuter","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"22","key":"ref30","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3748\/wjg.v17.i22.2740","article-title":"Ulcerative colitis in smokers, non-smokers and ex-smokers","volume":"17","author":"G Bastida","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1365-2036.1999.00630.x","article-title":"Effects of current and former cigarette smoking on the clinical course of Crohn's disease","volume":"13","author":"J Cosnes","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1053\/gast.2001.23231","article-title":"Smoking cessation and the course of Crohn's disease: an intervention study","volume":"120","author":"J Cosnes","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ibd.22959","article-title":"Does smoking influence Crohn's disease in the biologic era? The TABACROHN study","volume":"19","author":"T Nunes","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ajg.2015.401","article-title":"Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study","volume":"111","author":"T Nunes","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/gut.31.12.1377","article-title":"Inflammatory bowel disease and tobacco smoke\u2014a case-control study","volume":"31","author":"PG Persson","year":"1990","journal-title":"Gut"},{"issue":"30","key":"ref36","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","article-title":"Extraintestinal manifestations and complications in inflammatory bowel diseases","volume":"12","author":"KS Rothfuss","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"18","key":"ref37","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","article-title":"Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease","volume":"72","author":"G Trikudanathan","year":"2012","journal-title":"Drugs"},{"issue":"2","key":"ref38","first-page":"88","article-title":"Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"6","author":"Y Menachem","year":"2004","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/2050640615597835","article-title":"Crohn's disease and skin","volume":"4","author":"AG Gravina","year":"2016","journal-title":"United European Gastroenterol J"},{"issue":"22","key":"ref40","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3748\/wjg.v17.i22.2702","article-title":"Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?","volume":"17","author":"FT Veloso","year":"2011","journal-title":"World J Gastroenterol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T01:30:45Z","timestamp":1606181445000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210436"}},"subtitle":[],"editor":[{"given":"Pal Bela","family":"Szecsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210436","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]}}}